Saturday 17 October 2026 Export PCRX’s income statement to Excel — free account

Pacira BioSciences, Inc.

PCRX Healthcare Drug Manufacturers Specialty & Generic

Pacira BioSciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $726.4 million, up 3.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.24%, EPS grew 209.1%, free cash flow grew 502.5% and total debt fell 37.4%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

36.35 0.02 +0.06%

Follow PCRX

Alert me

Market cap: $1.5B
P/E: 104×
Fwd P/E: 33.7×
Dividend yield: —
F-score: 8/9
Altman Z: 2.02
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	72.49	188.33	172.53	56.02	+8 more quarters Free account
P/S ratio Full definition →	1.34	1.24	1.59	1.58
P/FCF ratio Full definition →	5.58	6.89	8.44	9.14
P/Operating CF Full definition →	17.42	35.61	26.40	18.66
P/B ratio Full definition →	1.49	1.40	1.66	1.56
Price to Tangible BV Full definition →	2.73	3.26	3.78	3.50
EV/Sales Full definition →	1.76	1.74	2.05	2.05
EV/EBITDA Full definition →	12.77	11.21	13.76	11.44
EV/Operating CF Full definition →	7.01	9.02	9.80	10.38
EV/FCF Full definition →	7.33	9.66	10.90	11.82
Quick Ratio Full definition →	3.14	3.01	3.01	3.38
Current Ratio Full definition →	5.04	4.73	4.54	5.26
Net Debt/EBITDA Full definition →	4.10	5.86	6.92	4.65
Debt/Assets Full definition →	29.19%	30.42%	29.42%	29.03%
Debt/Equity Full definition →	0.54	0.56	0.54	0.52
Asset Turnover Full definition →	0.54	0.53	0.52	0.51
Operating CF/Net income Full definition →	12.35	8.81	26.69	11.20
Capex/Depreciation Full definition →	(0.06)	(0.13)	(0.01)	(0.18)
Interest Coverage Full definition →	1.18	1.87	0.60	1.49
Research and Development Expense of Revenue Full definition →	15.72%	15.83%	19.20%	14.46%
Selling, General and Administrative Expense of Revenue Full definition →	47.72%	52.96%	51.61%	51.14%
Intangible Assets out of Total Assets Full definition →	0.25	0.31	0.31	0.31
Share Based Compensation of Revenue Full definition →	7.77%	7.63%	6.86%	7.79%
Graham Net Nets Full definition →	0.04	(0.04)	(0.02)	(0.01)
Graham Number Full definition →	11.58	6.61	7.25	13.07
Earnings Yield Full definition →	1.38%	0.53%	0.58%	1.79%
Free Cash Flow Yield Full definition →	17.93%	14.51%	11.85%	10.94%
Revenue per Share Full definition →	4.88	4.38	4.42	4.08
Operating CF per Share Full definition →	1.46	0.63	0.98	1.38
Capex per Share Full definition →	(0.03)	(0.07)	0.00	(0.09)
Free Cash Flow per Share Full definition →	1.42	0.57	0.98	1.29
Cash per Share Full definition →	6.36	5.00	5.35	5.59
Shareholders Equity per Share Full definition →	17.03	16.16	15.55	16.51
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	17.03	16.16	15.55	16.51
Free Cash Flow Full definition →	56.12	22.96	43.47	56.96
Working Capital Full definition →	493.20	406.17	427.38	455.67
Capital Expenditures Full definition →	(1.34)	(2.72)	(0.22)	(3.87)
Net Current Asset Value Full definition →	43.21	(39.68)	(23.83)	(7.61)
EV/EBIT Full definition →	66.21	53.20	77.62	35.32
Capex to Sales Full definition →	0.01	0.02	0.00	0.02
Price to Operating Income Full definition →	50.38	37.94	60.10	27.31
Other line items
Average Receivables Full definition →	123.39	115.19	118.69	107.96
Average Payables Full definition →	23.82	18.59	17.14	18.53
Average Inventory Full definition →	141.37	142.06	139.07	134.77
Average Assets Full definition →	1,390.62	1,397.60	1,409.22	1,409.63
Average Common Equity Full definition →	714.87	726.22	735.73	738.40

Fold the line items

Columns are period end dates

Stockrow Weekly